FDA NDC Directory · JSON-LD · Markdown

omeprazole

NDC 0363-1819 · HUMAN OTC DRUG · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Labeler / ManufacturerWalgreen Company
Marketing categoryNew Drug Application (innovator) · App NDA209400
Dosage form / routeTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE · ORAL
Active ingredientsOMEPRAZOLE (20 mg/1)
Marketing started20180301
Package count2

External sources

Source: openFDA. Public-domain (CC0).